InvAscent hits first close for new healthcare fund; strikes back-to-back PE deal

Premium

Homegrown healthcare-focussed private equity firm InvAscent has hit the first close for its latest fund, even as it struck a fresh investment in an active pharmaceutical ingredients maker.   InvAscent floated its fourth PE fund earlier this year, seeking to raise $300 million to $400 million in an attempt to push its ......